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Abstract
Background: Type III secretion systems (T3SS) of bacterial pathogens coordinate effector protein injection into
eukaryotic cells. The YscU/FlhB group of proteins comprises members associated with T3SS which undergo a
specific auto-cleavage event at a conserved NPTH amino acid sequence. The crystal structure of the C-terminal
portion of EscU from enteropathogenic Escherichia coli (EPEC) suggests this auto-cleaving protein provides an
interface for substrate interactions involved in type III secretion events.
Results: We demonstrate EscU must be auto-cleaved for bacteria to efficiently deliver type III effectors into
infected cells. A non-cleaving EscU(N262A) variant supported very low levels of in vitro effector secretion. These
effector proteins were not able to support EPEC infection of cultured HeLa cells. In contrast, EscU(P263A) was
demonstrated to be partially auto-cleaved and moderately restored effector translocation and functionality during
EPEC infection, revealing an intermediate phenotype. EscU auto-cleavage was not required for inner membrane
association of the T3SS ATPase EscN or the ring forming protein EscJ. In contrast, in the absence of EscU auto-
cleavage, inner membrane association of the multicargo type III secretion chaperone CesT was altered suggesting
that EscU auto-cleavage supports docking of chaperone-effector complexes at the inner membrane. In support of
this interpretation, evidence of novel effector protein breakdown products in secretion assays were linked to the
non-cleaved status of EscU(N262A).
Conclusions: These data provide new insight into the role of EscU auto-cleavage in EPEC. The experimental data
suggests that EscU auto-cleavage results in a suitable binding interface at the inner membrane that accommodates
protein complexes during type III secretion events. The results also demonstrate that altered EPEC genetic
backgrounds that display intermediate levels of effector secretion and translocation can be isolated and studied.
These genetic backgrounds should be valuable in deciphering sequential and temporal events involved in EPEC
type III secretion.
Background
Type III secretion systems (T3SS) of bacterial pathogens
translocate effector proteins into infected cells resulting
in a variety of modulations and disruptive actions to
host cellular processes. Examples include preventing
phagocytosis [1-4], altering Rho signalling [5,6], subvert-
ing intracellular membrane trafficking [7-10] and manip-
ulating innate immune responses [11-16].
T3SS are composed of at least 10 conserved proteins
[17] some of which are present in multiple copies. Spe-
cific protein components form an export apparatus
within the inner membrane. A needle complex is
formed using the general secretory pathway (sec system)
for some of the ‘ring’ forming components located in
the inner and outer bacterial membrane. Cryo-electron
microscopy studies of ‘needle complexes’ isolated from
Salmonella enterica serovar Typhimurium report a nee-
dle-like appendage with a central conduit of approxi-
mately 28 Angstroms [18,19]. For EPEC, ‘intact’ needle
complexes have been difficult to isolate [20] and there-
fore detailed structural information is lacking. A novel
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a polymeric EspA protein filament on top of a basal
needle complex [21]. The complete T3SS, composed of
the export apparatus and needle complex, then secretes
pore and filament forming proteins (EspA, EspB and
EspD translocator proteins [22]) and eventually effector
proteins, the latter of which are rapidly injected directly
into host cells during infection.
A conserved inner membrane protein found in all
T3SS is YscU (FlhB homologues). This group of proteins
has been the focus of considerable studies owing to an
interesting proteolytic activity. Specifically, FlhB/YscU
proteins undergo a post-translational intein-like auto-
cleavage event at a conserved NPTH amino acid
sequence, the result of which leads to proper secretion
system functionality [23,24]. Auto-cleavage occurs
between the asparagine and proline residues with the
resulting polypeptides remaining tightly associated
within the bacterial cell [25]. In Enteropathogenic E. coli
(EPEC), the auto-cleavage mechanism for its YscU
homologue, EscU, was elucidated through protein crys-
tallization studies [26]. The reaction mechanism occurs
at a type II b-turn and produces a conformational
change in EscU, spatially moving the histidine within
the NPTH region 180°. It was proposed that this striking
conformational change provides a new interface for pro-
tein interactions that are required for efficient secretion
[26]. In support of this interpretation, a non-cleaving
EscU variant (e.g. N262A) did not support type III pro-
tein secretion [26]. A soluble C-terminal EscU(P263A)
variant also remained un-cleaved in protein crystals,
although it was suggested that the reaction mechanism
could still occur at elevated pH or with slow kinetics.
The protein structures of other EscU homologues
(YscU, Spa40) have shown similar auto-cleavage
mechanisms [27-29] indicating a remarkable functional
importance for this proteolytic event in secretion events.
In all cases, the YscU homologue is an essential compo-
nent of the respective secretory apparatus, however,
t h e r ei sc o n s i d e r a b l ev a r i a b i lity amongst bacteria in the
secretory phenotypes that are associated with YscU or
FlhB auto-cleavage. In the case of Y. enterocolitica,n o n -
cleaving YscU variants were found to support secretion
of type III effector proteins but not translocator proteins
suggesting that YscU auto-cleavage serves to recognize
translocators for type III secretion in this pathogen [30].
In two other Yersinia species, Y. pestis and Y. pseudotu-
berculosis, non-cleaving YscU forms showed dramatic
reduction of effector and translocator protein secretion
compared to the respective wild type strains suggesting
a modulating role for the YscU auto-cleavage event
[24,31]. In the plant pathogen Xanthomonas campestris,
the C-terminal region of HrcU was demonstrated to
interact with the putative substrate switching protein
HpaC, leading to effector secretion. With respect to fla-
gellum biogenesis, an uncleaved form of FlhB (a YscU
homologue) was demonstrated to selectively export only
rod/hook-type protein substrates but not filament type
substrates [32]. This observation is in line with a modu-
latory or substrate switching role for FlhB auto-cleavage.
From all these studies, it appears that the context of the
YscU homologue and its interactions with other secre-
tory components influence T3SS function. It remains
that auto-cleavage function is likely contextual and may
have specific secretory consequences in different
bacteria.
In this study, we provide experimental evidence that
EscU auto-cleavage in EPEC promotes effector protein
translocation into host cells during infection. In the
absence of EscU auto-cleavage, very low levels of effec-
tor proteins were secreted as non-functional and abnor-
mal forms. EscU auto-cleavage also promoted efficient
membrane association of the multicargo type III chaper-
one CesT, which has implications for effector delivery
into cells during infection.
Results
Uncleaved forms of EscU support low levels of
translocator and effector protein secretion into culture
supernatants
Based on previous protein crystallography studies [26],
we generated three recombinant plasmids that encode
auto-cleaved or uncleaved histidine tagged forms of
EscU (39 kDa) (see Materials and Methods). EscU-HIS
(pJLT21), EscU(N262A)-HIS (pJLT22) and EscU
(P263A)-HIS (pJLT23) were created for initial character-
ization studies. Unlike Shigella species where Congo
R e di su s e dt o‘induce’ in vitro type III secretion [33],
culturing EPEC in DMEM ‘induces’ type III secretion
[34,35]. After culturing for 6 hours in DMEM, whole
cell lysates and culture supernatants were collected from
ΔescU strains harbouring pJLT21, pJLT22 and pJLT23.
EscU auto-cleavage at the NPTH catalytic site is pre-
dicted to produce an 89 amino acid C-terminal product
of 10.3 kDa. Immunoblotting whole cell lysates indicated
that EscU-HIS was auto-cleaved due to the detection of
an approximately 10 kDa species with anti-HIS antibo-
dies (Figure 1A). A longer immunoblot exposure did
not reveal any uncleaved EscU (39 kDa) suggesting com-
plete auto-cleavage. In contrast, ΔescU whole cell lysates
containing EscU(N262A) or EscU(P263A) produced a 39
kDa species detected by anti-HIS antibodies, a molecular
weight consistent with uncleaved (intact) EscU.
To further characterize these strains, the respective
culture supernatant fractions were evaluated. Under
these growth conditions, four predominant protein spe-
cies are routinely detected in secretion fractions and
have been identified using protein micro-sequencing
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Figure 1 Efficient translocon and effector secretion is dependent on EscU auto-cleavage. (A): Immunoblot demonstrating EscU variant
cleavage status within whole cell lysates. The blots were imaged separately to get representative signals for the auto-cleavage products. A
longer exposure was used for the 39 kDa protein species. (B) Left: trans-complementation of ΔescU with pJLT21 restores EspA (~20 kDa), EspB
and EspD (co-migrate ~30 kDa) secretion to wild type levels (the identity of these dominant protein species has been previously determined
using protein sequencing [36], and here by immunoblotting [right panel]). EspC is an abundant type 5 secreted protein. Bovine serum albumin
(BSA) was added to collected secreted protein fractions as a carrier protein to assist in the precipitation of proteins. A molecular weight standard
is in the left most lane. Right: immunoblot analyses of secreted protein and whole cell lysate fractions from bacterial strains used in panel A (as
indicated). The respective secreted protein fractions were diluted 20 fold prior to SDS-PAGE. (C) Left: secreted protein fractions derived from
ΔescNΔescU double mutant strains with the indicated plasmids. Right: Immunoblot analysis of secreted protein fractions. DnaK, an abundant non-
secreted cytoplasmic protein, was used as a gel loading control (when needed) or to assess cytoplasmic contamination of secreted fractions or
non-specific bacterial lysis. All samples were diluted 20 fold as in panel B. All experiments within the panels were performed twice and
representative images are shown.
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Page 3 of 17[36]. These include EspA (predicted molecular mass of
20.5 kDa, filamentous translocon protein [37], EspB
(predicted molecular mass of 33 kDa, YopD orthologue),
EspD (predicted molecular mass of 39.5 kDa, YopB
orthologue) and EspC (predicted molecular mass 140
kDa, secreted by the type V secretion pathway). In con-
trast, low amounts of Tir and other type III effectors are
secreted under these conditions but can be detected
using immunoblotting approaches. As expected, ΔescU
expressing EscU-HIS restored EspA, EspB and Tir pro-
tein secretion back to wild type EPEC levels (Figure 1B).
ΔescU expressing either EscU(N262A) or EscU(P263A)
had visibly lower amounts of protein species in their
respective secretory profiles, however, a notable ~30kDa
protein species was detected by Coomassie staining and
could represent low levels of either EspB or EspD (pre-
dicted molecular masses of 33 and 39.6 kDa respec-
tively). Immunoblotting with anti-EspA, anti-EspB and
anti-Tir antibodies demonstrated reduced levels of EspA
(~20%), EspB (~20%) and Tir (~70%) from ΔescU bac-
teria expressing either EscU(N262A) or EscU(P263A)
relative to EscU (as determined by densitometric ana-
lyses). Immunoblotting the whole cell lysates of these
strains demonstrated equal steady state amounts of
EspA, EspB and Tir were present, ruling out the possibi-
lity of intracellular protein expression differences.
Immunoblotting the same whole cell lysate samples with
anti-EscC and anti-EscJ antibodies revealed equal
amounts of the type III secretion apparatus ring forming
proteins EscC and EscJ. This latter result indicates that
EscC and EscJ protein expression levels are not altered
by the cleavage status of EscU.
An ΔescNΔescU double mutant was generated to
investigate if non-specific leakage from bacterial cells
was occurring (perhaps due to overexpression of EscU
or multi-copy effects). In the absence of EscN, the
ATPase of the EPEC T3SS, type III secretion does not
occur [38]. EspA, EspB and Tir were not observed in
the secreted sample from the ΔescNΔescU double
mutant by Coomassie staining (Figure 1C). Immunoblot-
ting using antibodies against EspA, EspB and Tir did not
detect these proteins in the ΔescNΔescU secretion frac-
tion. Genetic complementation of ΔescNΔescU with
plasmids expressing wild type EscN and EscU restored
the secretion of EspA, EspB and Tir to wild type levels
indicating that this double mutant strain could be res-
cued with multicopy plasmids expressing the appropri-
ate proteins. Complementation of ΔescNΔescU with
plasmids pJLT21, pJLT22 and pJLT23 (in the absence of
pEscN) did not result in EspA, EspB and Tir secretion
as assayed by Coomassie staining and immunoblotting
(Figure 1C). Based on these data, the small amount of
EspA, EspB and Tir in culture supernatants for ΔescU/
pJLT22 and ΔescU/pJLT23 (Figure 1B and 1C) was due
to EscU(N262A) or EscU(P263A) expression, and was
EscN dependant. Importantly, plasmid mediated genetic
complementation does not introduce leakage artefacts to
the experimental system.
The 10 kDa EscU auto-cleavage product is membrane
associated
The observation that uncleaved forms of EscU support
very low levels of type III translocon and effector pro-
tein secretion was unexpected since EscU auto-cleavage
has been suggested to provide a binding interface for
protein substrate recognition at the base of the T3SS
[26]. We therefore set out to evaluate the cleavage state
of our EscU variants within sub-cellular fractions
enriched for T3SS needle complexes.
To assess EscU auto-cleavage and to detect post-auto-
cleavage products, we generated double tagged recombi-
nant EscU forms. A hemagglutinin (HA) tag was fused
to the N terminus and a FLAG tag was fused to the C-
terminus of EscU. Using this strategy, wild type EscU
auto-cleavage is predicted to produce a 29 kDa trans-
membrane polypeptide that can be recognized by anti-
HA antibodies and a 10 kDa cytoplasmic polypeptide
(amino acids 263-345) that can be recognized by anti-
FLAG antibodies. ΔescU/pJLT24 (expressing HA-EscU-
FLAG) demonstrated a wild type EPEC secretion pattern
indicating that the presence of HA and FLAG tags did
not inhibit EscU function (data not shown). A sub-cellu-
lar fractionation procedure to produce a membrane
fraction enriched for T3SS needle complexes [39] was
then used to evaluate the double tagged protein con-
structs in the escU null mutant. The membrane prepara-
tion derived from ΔescU/pJLT24 was probed with anti-
HA antibodies and anti-FLAG antibodies which detected
29 and 10 kDa polypeptide species respectively (Figure
2). These polypeptide species are in complete agreement
with the predicted sizes of EscU auto-cleavage products.
No full-length EscU (39 kDa) was detected in the
ΔescU/pJLT24 membrane fraction, suggesting complete
auto-cleavage had occurred under these conditions.
EscU(N262A) was detected exclusively at 39 kDa with
anti-HA antibodies. Interestingly, EscU(P263A) appeared
as a 39 kDa polypeptide along with a 29 kDa and 10
kDa polypeptides detected by anti-HA antibodies and
anti-FLAG antibodies respectively. These data demon-
strate that the EscU 29 and10 kDa auto-cleavage pro-
ducts localized to membrane fractions enriched for
T3SS needle complexes and are in agreement with the
crystal structure soluble domain interactions previously
reported [26]. In addition, plasmid encoded EscU
(P263A) is auto-cleaved in EPEC albeit at reduced levels
compared to normal EscU.
The formation of functional T3SS needle complexes is
believed to be a multistep process. For EPEC, T3SS
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of Salmonella and Shigella species. Purified EPEC T3SS
needle complex preparations often lack certain protein
components that are highly conserved in all systems and
h e n c ee x p e c t e dt ob ep a r to fa‘complete’ T3SS needle
complex. For example EscF, the putative needle protein
has not been detected in highly purified EPEC needle
preparations [20]. Antibodies to EscJ and EscN [39]
were used to probe membrane fractions to assess the
expression levels of these proteins. No change in the
amount of cell envelope associated EscJ or EscN was
observed in ΔescU bacteria expressing any of the EscU
v a r i a n t s( F i g u r e2 Aa n d2 B ) .T h e s ed a t ai n d i c a t et h a t
EscU auto-cleavage is not essential for EscN and EscJ
localization to the cell envelope. In certain Yersinia and
Shigella mutant genetic backgrounds and under defined
growth conditions, the T3SS needle proteins (YscF or
MxiH) are secreted in higher amounts [30,31,40] Since
no one has detected polymerized EscF (needle protein)
in purified EPEC needle complexes or secreted protein
fractions, we are currently unable to assess whether
EscU auto-cleavage is required for EscF polymerization
or EscF protein secretion (see discussion).
EscU auto-cleavage is necessary for functional
translocation of type III effector proteins into human cells
The role of EscU auto-cleavage in effector injection dur-
ing EPEC infection has not been evaluated. We there-
fore set out to evaluate the role of EscU auto-cleavage
during EPEC infection of human cells. We used C-
terminal HIS tagged EscU forms for these experiments
as we noted the complementation efficiency for these
constructs were better than the dual HA and FLAG
tagged constructs (data not shown). escU mutants
expressing EscU-HIS variants were tested for their abil-
ity to translocate (inject) the effector Tir into human
cells. While the EPEC bundle forming pilus (BFP) is
known to mediate early and initial adherence to host
cells during infection, T3SS mediated Tir translocation
into host cells is required for intimate EPEC adherence
(mediated by a Tir/Intimin interaction). In addition, Tir
translocation results in F-actin ‘pedestal’ structures
directly beneath adherent bacteria. As expected after a
three-hour infection, it was found that the ΔescU infec-
tion had markedly fewer bacteria intimately associated
to HeLa cells (compared to the wild type infection) and
could not induce host cell F-actin rearrangement (Figure
3A). Infection with ΔescU/pJLT21 fully restored intimate
adherence and F-actin pedestal structures to wild type
levels, indicating that EscU is required for pedestal for-
mation. The EscU(N262A) variant encoded by ΔescU/
pJLT22 had similar defects in intimate adherence and
pedestal formation as ΔescU (Figure 3A). In contrast,
EscU(P263A) supported an apparent increase in bacter-
ial intimate adherence and formed short actin pedestals
(see inset). Notably all strains express BFP, suggesting
that the intimate adherence differences are related to
T3SS and EscU function. We further quantified the
number of intimately adherent bacteria by microscopic
counts. These analyses revealed a significant deficiency
Figure 2 EscU auto-cleavage results in a 10 kDa C-terminal product that is membrane associated in EPEC. (A) Isolated membrane
fractions were probed with anti-HA and anti-FLAG antibodies to assess EscU auto-cleavage status. Membrane localization of EscJ is unchanged
in escU null mutants (lane 2) and therefore this protein served as an internal control for the individual membrane fractions. The approximate 10
kDa C-terminal EscU auto-cleavage product (detected with anti-FLAG antibodies) along with the 29 kDa HA-tagged N-terminal product (detected
with anti-HA antibodies) both partitioned to the membrane fraction (denoted by arrows). Uncleaved EscU is also membrane associated and
appeared as a 39 kDa species. (B) The same membrane fractions were probed with anti-EscN antibodies to detect membrane associated EscN
levels. A ΔescN mutant membrane preparation was included to demonstrate the specificity of the antibody.
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escU expressing EscU(N262A) (Figure 3B).
To further support the Tir injection and actin pedestal
observations, we employed a Tir-TEM-1 b-lactamase
fusion protein (expressed in EPEC and ΔescU strains) to
report on Tir translocation. This approach uses living
cells loaded with a fluorescent substrate that can be
cleaved by b-lactamase and has been used in EPEC/
EHEC/Citrobacter to quantitatively monitor type III
effector translocation [41-45]. Using this approach, a
Tir-TEM-1 fusion protein was translocated by wild type
EPEC but not ΔescU (Figure 3C). ΔescU/pJLT21 demon-
strated translocation of Tir-TEM-1 near wild type levels
while ΔescU/pJLT23 supported significantly less translo-
cation albeit above ΔescU levels. ΔescU/pJLT22 was
unable to support Tir-TEM1 translocation and appeared
Figure 3 EscU auto-cleavage is required for Tir translocation, actin pedestal formation and maximal intimate EPEC adherence.( A )
Fluorescent microscopy images of HeLa cells following a three-hour infection with various EPEC strains. Phalloidin staining (red) was used to
detect F-actin. All EPEC strains contain a plasmid that encodes GFP (green). Note the strong F-actin enrichment (red signal) within the boxed
insets. This experiment was performed twice and representative merged images are shown. (B) Quantification of intimately adherent bacteria
using a binding index. The bacterial binding index was defined as the percentage of cells with at least five bound bacteria that co-localized to
actin pedestals. At least 50 cells were counted per sample. (C) A Tir-TEM1 effector translocation assay was used to quantify translocation levels
during infection of HeLa cells. HeLa cells were infected with the indicated bacterial strains, washed twice to remove non-adherent bacteria and
then loaded with the cell permeable fluorescent b-lactamase substrate CCF2/AM. Blue and green (460 and 530 nm) signals were detected with a
plate reader and the fluorescence ratio (460/530 nm) corrected for background is shown for the indicated strains. An immunoblot of whole cell
lysates with anti-TEM1 antibodies demonstrated equivalent amounts of b-lactamase in the five strains with pTir-bla (inset). The presented
translocation assay data are averages of triplicate values of the results from three independent experiments.
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strains with auto-cleaved forms of EscU supported the
translocation of Tir-TEM-1 fusion proteins into infected
HeLa cells whereas strains with uncleaved EscU or the
absence of EscU did not.
In the absence of EscU auto-cleavage, novel Tir
polypeptides are detected in culture supernatants
T h eH e L ac e l li n f e c t i o ne x p e riments established a sub-
stantial role for EscU auto-cleavage in Tir and presum-
ably other type III effector injection by EPEC. The in
vitro secretion assay experiments shown in Figure 1
reveal predominant EPEC translocon protein secretion
(EspABD) and very low levels of effector proteins. In
contrast, EPEC sepD mutants are known to hyperse-
crete abundant levels of type III effector proteins
under the same growth conditions, including Tir,
NleA, NleH, NleG and EspZ among others [35,39]
(also see Figure 4A). We reasoned that the ΔsepD
EPEC strain would be a suitable genetic background to
gain some insight into the role of EscU auto-cleavage
with respect to in vitro type III effector secretion. A
ΔsepDΔescU double mutant was generated and grown
under secretion inducing conditions followed by col-
lection of the secreted protein fractions. The secreted
protein fraction derived from ΔsepDΔescU was visibly
lacking many protein species compared to that of
ΔsepD (Figure 4A). Trans-complementation of Δsep-
DΔescU with pJLT21 restored secretion back to that of
ΔsepD with respect to protein amounts and profile. In
contrast, the ΔsepDΔescU/pJLT22 did not restore a
ΔsepD secretion profile. Interestingly, ΔsepDΔescU/
pJLT23 secreted low amounts of a protein species with
a similar apparent molecular mass as Tir (Figure 4A).
Untagged cis-complemented sepD::escU(N262A) and
sepD::escU(P263A) strains (expressing the respective
escU allele from the chromosome) were generated by
allelic exchange and were found to produce the same
secretion profile as the respective plasmid complemen-
ted strains (Figure 4A). Immunoblotting with monoclo-
nal anti-Tir antibodies revealed that Tir secretion
occurred at variable levels when EscU or EscU variants
were expressed although for EscU(N262A), a novel
lower molecular weight polypeptide was detected with
anti-Tir antibodies (Figure 4B). This novel polypeptide
species was consistently absent from ΔsepDΔescU/
pJLT21 or pJLT23 and the parent ΔsepD strain.
CesT membrane localization is altered in the absence of
EscU auto-cleavage
In a previous report, we have demonstrated that the
multicargo type III chaperone CesT mediates effector
‘docking’ at the inner membrane in an EscN-dependent
manner [39]. CesT is also required for Tir stability in
the EPEC cytoplasm [46,47] and mediates efficient
secretion of at least 9 type III effectors [39]. It has also
been demonstrated that CesT contributes to effector
translocation [42,43]. The detection of a small novel Tir
polypeptide in culture supernatants derived from bac-
teria expressing EscU(N262A) suggested that CesT-Tir
interactions may be altered in the absence of auto-clea-
vage. We therefore set out to investigate CesT-Tir,
CesT-EscU interactions in context of EscU auto-clea-
vage using bacteria that expressed HA-tagged EscU var-
iants. Total cell lysates and membrane preparations
were generated from the ΔescU mutant expressing
either EscU, EscU(N262A) or EscU(P263A) followed by
SDS-PAGE and immunoblotting analyses. Total CesT
levels were unchanged in all the strains, indicating that
EscU auto-cleavage does not influence CesT protein
expression or stability (Figure 5). As reported previously
[39], CesT was detected within the membrane fraction
for wild type EPEC (Figure 5). Band intensity (chemilu-
m i n e s c e n ts i g n a l s )w a sq u a n tified using densitometry
normalized to EscJ levels within the same membrane
fraction. A reduced amount of membrane associated
CesT was observed for ΔescU and ΔescU expressing
either EscU(N262A) or EscU(P263A), as determined by
densitometric analyses. The reduced amount was statis-
tically significant for the escU null mutant compared to
wild type EPEC, although this significance did not
extend to the EscU variants. Next, the membrane frac-
tions were subjected to sucrose gradient fractionation to
assess CesT membrane localization patterns. EscJ and
intimin are inner and outer membrane proteins respec-
tively and hence served to identify inner and outer
membrane enriched fractions. For ΔescU expressing
HA-EscU-FLAG, a strong enrichment of CesT was
found within inner membrane fractions. In contrast,
HA-EscU(262)-FLAG and HA-EscU(263)-FLAG showed
a more diffuse pattern of CesT membrane association,
with a considerable amount of CesT protein localizing
to less dense fractions within the gradient. These obser-
vations suggested that CesT function could be altered or
less efficient in the absence of EscU auto-cleavage. We
therefore carried out a co-immunoprecipitation assay,
using anti-CesT antibodies, to assess CesT-effector
interactions. Moreover, it has been shown that HpaB, a
type III chaperone, interacts with HrcU [48] (EscU
homologue) and hence we asked whether CesT interacts
with EscU. Affinity purified anti-CesT antibodies co-
immunoprecipitated equal amounts of Tir from all bac-
terial lysates (Figure 6). This was expected, since CesT
is required for Tir stability [46,47], and an earlier result
that showed equal steady state levels of Tir in whole cell
lysates expressing EscU variants (Figure 1). In contrast,
both auto-cleaved and un-cleaved forms of EscU were
not co-immunoprecipitated with anti-CesT antibodies.
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Page 7 of 17Figure 4 EscU auto-cleavage is required for efficient and stable effector secretion in an EPEC ΔsepD genetic background. (A) Left: Trans-
complementation of ΔsepDΔescU with pJLT21 restored secretion of effectors to ΔsepD levels while ΔsepDΔescU/pJLT22 did not restore normal
effector secretion. ΔsepDΔescU/pJLT23 secreted a protein with an apparent molecular mass similar to Tir (asterisk). The dominant effector proteins
are labelled and have been previously identified using mass spectrometry analyses [35]. Purified BSA was added to collected secreted fractions
and served to aid in protein precipitation. Right: genomic integration of mutant escU alleles (cis-complementation, single copy) produces the
same secretion phenotypes as the plasmid trans-complemented escU strains. Total secreted proteins were visualized by Coomassie G-250
staining. (B) Secreted protein preparations were analyzed by immunoblot with anti-Tir antibodies. Due to the abundance of secreted Tir in ΔsepD
and ΔsepDΔescU/pJLT21, (see Coomassie stain in panel A), only these samples were diluted 20 fold for immunoblotting purposes while the
others were undiluted. A ΔsepDΔtir strain (undiluted) was included to show the specificity of the anti-Tir antibodies. Lower molecular weight
protein species are therefore Tir breakdown products that were consistently observed and recognized by the anti-Tir antibodies. A novel Tir
polypeptide, indicated by an arrow, was exclusively detected in the lane containing secreted proteins derived from ΔsepDΔescU/pJLT22.
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Page 8 of 17Figure 5 CesT membrane association is reduced in the absence or with limited EscU auto-cleavage. (A) Total cell lysates and membrane
fractions were probed with anti-CesT antibodies to assess CesT protein levels. The membrane fraction immunoblot was subjected to
quantification of band intensity (chemiluminescent signals) to measure CesT protein levels relative to EscJ. EscJ forms a multimeric ring like
structure (independent of EscU) and localizes to the inner membrane. For quantification via densitometry, the immunoblots were probed with
antibodies and then simultaneously imaged using an exposure time within an empirically determined linear range of signal detection. The
densitometry values are averages from three independent experiments and are expressed as a ratio of CesT/EscJ signals as assayed by Quantity
One software. A dependent, match paired student’s t test was used to assess statistical significance between values (denoted by an asterisk). A
representative immunoblot from the experiments is shown. (B) Sucrose density gradient fractionation of membrane preparations from the
indicated strains. EscJ and intimin are known inner and outer membrane proteins and their immune-detection served to indicate fractions
enriched for inner and outer membranes separated upon ultracentrifugation. Note the altered distribution of CesT in the presence of EscU
(N262A) and EscU(P263A).
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Page 9 of 17Taken together, these data indicate that total CesT
membrane levels were not statistically different for EscU
variant expressing strains, although the nature of CesT
association with the inner membrane was altered in the
absence or with limited EscU auto-cleavage. CesT
retained normal effector binding function in the absence
of EscU auto-cleavage and EscU did not co-immunopre-
cipitate with CesT.
Discussion
The T3SS is one of the most complex secretory systems
in prokaryotic biology, being composed of at least 10
conserved protein components [17]. The YscU/FlhB
proteins have been studied in considerable detail,
although the phenotypes associated with secretion are
highly variable among bacteria and even within the
same species [24,30-32,49,50]. The intein-like auto-clea-
vage mechanism of EscU was previously elucidated
through protein crystallography studies. It was proposed
that EscU auto-cleavage likely results in an interface for
important protein interactions for type III secretion. In
this study, we provide evidence to suggest that EscU
auto-cleavage supports efficient type III effector
translocation. We also observed that the multicargo type
III chaperone CesT was less efficiently associated with
t h ei n n e rm e m b r a n e( F i g u r e6 ) ,w h i c hm a yp a r t l y
explain the deficiency in type III effector translocation.
T h ed a t ae x t e n dp r e v i o u sf i n d i n g sp e r t a i n i n gt oE s c U
auto-cleavage and suggest a critical role for EscU auto-
cleavage in preparing the secretory apparatus to accept
chaperone-effector complexes.
Previous studies have demonstrated that escU null
mutants are completely deficient in secreting proteins
via the T3SS pathway [26,51]. This phenotype holds
true in other pathogens with T3SS and therefore high-
lights the absolute requirement of YscU/FlhB proteins
in type III secretion events. Very little is known regard-
ing how substrate proteins engage the EPEC T3SS
export apparatus (EscRSTUV) located in the inner
membrane. A non-cleaving EscU(N262A) variant still
supported the secretion of Tir although at least one
novel Tir derived polypeptide (possibly due to degrada-
tion) was linked to the uncleaved state of EscU(N262A).
In contrast, bacteria expressing EscU(P263A) did not
display novel Tir degradation products which suggests
that its low level auto-cleavage is sufficient to support
Figure 6 EscU or EscU variants from EPEC lysates do not co-purify with immunoprecipitated CesT. Cell lysates were generated from the
indicated bacterial strains and exposed to anti-CesT antibodies in a co-immunoprecipitation experiment. The lysate inputs were probed with the
indicated antibodies (top panel). Anti-RNA polymerase antibodies were used to detect RNA polymerase amounts within the lysates which are
expected to be equivalent. The elution fractions were probed with the indicated antibodies. tir and cesT null mutants were included as control
strains in the experiment. Note that Tir is unstable in the absence of CesT and therefore was not detected in the elution fraction. The lane
designations apply to all the panels.
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Page 10 of 17Tir stability and secretion. We did observe reduced
levels of membrane associated CesT in the absence of
EscU auto-cleavage, although the result was not statisti-
cally significant. Our efforts to further explore this
observation using other approaches included separating
membrane preparations by sucrose density gradients.
These analyses revealed that CesT membrane associa-
tion is less stable without or with minimal EscU auto-
cleavage (Figure 5B). Sucrose gradient membrane frac-
tionation is a challenging biochemical technique, and
gradient to gradient comparisons and exact gradient
reproducibility are difficult. We are in the process of
developing in situ approaches such as fluorescence
energy transfer (FRET) to better assess protein interac-
tion at the base of the T3SS. Nonetheless, the presented
experiments provide a framework for future experiments
and demonstrate that the presence of auto-cleaved EscU
supported localized CesT membrane association.
Recently, Galan and co-workers reported that type III
chaperones associate with a ‘sorting platform’ within the
cytoplasm and that this chaperone association influences
secretory events [52]. A platform has yet to be identified
in EPEC, although it is possible that within our experi-
mental system, CesT may be mis-localized leading to
aberrant type III effector secretion. The observation of
degraded Tir due to EscU(N262A) (Figure 5B) is in line
with this interpretation. Furthermore, the short actin
pedestals directly underneath adherent EscU(P263A)
expressing bacteria which showed reduced auto-cleavage
levels is consistent with this view. Since EPEC Tir injec-
tion strictly requires a EspABD translocon [53-56] and
EspA filament formation requires EscF expression [57],
EscU(P263A) likely supports the formation of a func-
tional T3SS needle apparatus (at reduced levels) formed
by the putative needle protein EscF and the translocon
proteins EspA, EspB and EspD. We performed three dif-
ferent, yet complimentary infection assays (immuno-
fluorescent microscopy, sub-cellular fractionation and
effector b-lactamase fusions) to characterize EscU
(P263A) and consistently identified intermediate effector
translocation levels. Interestingly, a similar intermediate
phenotype was observed for a Salmonella flhB null
mutant expressing a slow cleaving FlhB(P270A) protein
where cells were weakly motile and exported reduced
amounts of flagellin [32].
Chaperone-effector complex docking at the inner
membrane has been reported for many T3SS [58,59].
We have previously demonstrated that CesT inner
membrane association is aided by the presence of the
T3SS ATPase EscN [39]. The data cannot rule out the
possibility that the EPEC T3SS export apparatus may be
structurally impaired or malformed in the presence of
uncleaved EscU although it has been demonstrated that
un-cleaved forms of EscU can fold correctly [26]. The
levels of EscN (T3SS ATPase) were unchanged in ΔescU
bacteria expressing uncleaved or partially uncleaved
forms of EscU (Figure 2B). Since bacteria expressing
EscU(P263A) did support effector translocation, albeit at
a reduced level, a functional T3SS export apparatus was
likely assembled even though EscU(P263A) was only
partially auto-cleaved. In support of this, within S. typhi-
murium, uncleaved SpaS (EscU homologue) still sup-
ported the formation of a high order export apparatus -
needle complex composed of at least 10 proteins as
s h o w nb yb l u en a t i v e( B N )P A G Eo fe n r i c h e dn e e d l e
complex containing fractions [60].
A number of studies have reported on specific pro-
tein-protein interactions important for T3SS function.
Auto-cleavage of HrcU (an EscU homologue in Xantho-
monas) promoted an interaction between the ATPase
HrcN, and the C-terminal cleavage product of HrcU
[48]. The global T3S chaperone HpaB was also shown
to interact with HrcN and the full-length form of HrcU.
Co-immunoprecipitation experiments using EPEC
lysates and anti-CesT antibodies failed to detect an
interaction with EscU or non-cleaving EscU variants
(Figure 6). Although we cannot rule out the possibility
of a direct CesT-EscU interaction, we provide evidence
that efficient CesT membrane association occurs when
EscU is auto-cleaved (Figure 5A).
It has been demonstrated that the YscU/FlhB proteins
interacts with multiple components within their respec-
tive T3SS [24,60-62]. A shortlist of protein interactions
includes YscI, YscK, YscL, YscN, YscQ and YscV (using
the Yersinia nomenclature) among other proteins. The
putative YscL, YscI and YscQ homologues within the
EPEC LEE PAI are believed to be Orf5, rOrf8 and SepQ
respectively [63] although the homology scores are very
low (below 15%). A yeast two hybrid screen identified
rOrf8 (putative YscI homologue) as an EscU binding
partner [64]. The YscI/PrgJ family form an inner rod
within the T3SS needle complex, a structure that may
exist for EPEC but has not been identified in highly pur-
ified needle preparations [20]. In Shigella,S p a 3 2i s
known to interact with the C-terminal region of Spa40
[40], however in EPEC an evident Spa32 homologue has
not been identified. The notable absence of clear homo-
logues for known YscU protein partners is puzzling
although might be explained by the different architec-
ture of the EPEC T3SS compared to Salmonella, Shi-
gella and Yersinia. Specifically, a long polymeric
filament composed of EspA sits atop the EPEC needle
complex [21].
From the various crystal structures now available, it
has been hypothesized that the conserved auto-cleavage
mechanism for the YscU/FlhB group of proteins results
in a critical surface to promote protein interactions for
secreted substrates [26-29]. We extend this
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Page 11 of 17interpretation with experimental data to further suggest
that EscU auto-cleavage promotes translocon and effec-
tor protein secretion presumably by acting at the base
of the EPEC T3SS.
Conclusions
This study provides evidence that intermediate pheno-
types can be identified in the EPEC T3SS secretory
pathway suggesting that sequential binding events are
involved in type III effector translocation into host cells.
The conserved mechanism of auto-cleavage, shown here
for EscU, is a critical event that supports type III effec-
tor translocation. Additional studies will be required to
identify the temporal sequence of events and to func-
tionally characterize how protein substrates are traf-
ficked through the T3SS.
Methods
Bacterial Strains and Growth Media
Bacterial strains generated and used in this study are
listed in Table 1. Bacterial strains were routinely cul-
tured in Luria broth (LB) (1% [w/v] tryptone, 0.5% [w/v]
yeast extract, 1% [w/v] NaCl) at 37°C. Antibiotics
(Sigma) were added when appropriate, to a final concen-
tration of 50 μg/ml kanamycin, 50 μg/ml streptomycin,
30 μg/ml chloramphenicol, 200 μg/ml ampicillin, 10 μg/
ml tetracycline.
Isolation of Genomic and Plasmid DNA
Genomic DNA was isolated from bacterial strains using
the Purogene genomic DNA isolation kit (Gentra sys-
tems). Plasmids were isolated from bacterial strains
using the QIAprep spin miniprep kit (Qiagen).
Recombinant Plasmid Construction
The escU gene was amplified via polymerase chain reac-
tion (PCR) from EPEC genomic DNA using primers JT8
and JT10 and cloned into pET21a+ to create pETescU-
HIS (see table 2 for the sequences and list of primers
used in this study). This construct overexpresses EscU-
His from the recombinant T7 promoter. The pETescU
(N262A)HIS and pETescU(P263A)HIS vectors were gener-
ated using the Phusion site directed mutagenesis kit
(Finnzymes), following the manufacturer’sd i r e c t i o n s .
Table 1 Strains and plasmids used in the study
Strains Description Source/comment
Wild type EPEC EPEC strain E2348/69, streptomycin-resistant, BFP positive. [35]
ΔescU escU deletion mutant This study
ΔsepD sepD deletion mutant
ΔsepDΔescU Double mutant derived from ΔsepD This study
ΔsepD::escU(N262A) Cis-complemented ΔsepDΔescU strain This study
ΔsepD::escU(P263A) Cis-complemented ΔsepDΔescU strain This study
ΔsepDΔtir Double mutant derived from ΔsepD [35]
ΔescNΔescU Double mutant derived from ΔescN This study
SM10lpir E. coli strain that is permissive for pRE112 replication
DH5a E. coli strain used for cloning
DH5alpir E. coli strain used for cloning, permissive for pRE112 replication
Plasmids
pET21 a+
pACYC184
T7/HIS tagged fusion vector
Broad host range plasmid, P15A derived
Novagen
[72]
pETescUHIS pET21a+ expressing EscU-HIS This study
pETescU(N262A)HIS pET21a+ expressing EscU(N262A)-HIS This study
pETescU(P263A)HIS pET21a+ expressing EscU(P263A)-HIS This study
pEscN pACYC184 expressing EscN [65]
pFLAG-CTC Cloning vector to express C-terminal FLAG fusion proteins from tac promoter Sigma
pJLT21 pACYC184 expressing EscU-HIS This study
pJLT22 pACYC184 expressing EscU(N262A)-HIS This study
pJLT23 pACYC184 expressing EscU(P263A)-HIS This study
pJLT24 pFLAG-CTC backbone vector that expresses a HA-EscU-FLAG tagged protein This study
pJLT25 pFLAG-CTC backbone vector that expresses a HA-EscU(N262A)-FLAG tagged protein This study
pJLT26 pFLAG-CTC backbone vector that expresses a HA-EscU(P263A)-FLAG tagged protein This study
pRE112 lpir origin, suicide vector encoding sacB [73]
PΔescU escU deletion fragment cloned into pRE112 suicide vector This study
pTir-bla pCX341 expressing a Tir-TEM1 fusion protein This study
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Page 12 of 17Briefly, primers pairs JT12/JT13 and JT14/JT15, that had
phosphorylated 5’ ends, were used to generate ampli-
cons of pETescU(N262A)HIS and pETescU(P263A)HIS
using pETescUHIS as template. The sequences of pETes-
cUHIS,p E T escU(N262A)HIS and pETescU(P263A)HIS
were verified using the universal T7 forward and reverse
primers that flank the pET21a+ multiple cloning site by
sequencing.
To generate pJLT21, pJLT22 and pJLT23, DNA frag-
ments corresponding to the relevant escU allele were
amplified by PCR using primers JT8 and JT10 from iso-
lated plasmid DNA of pETescUHIS,p E T escU(N262A)HIS
and pETescU(P262A)HIS, respectively. The resulting 1.5
kb products were purified and treated with restriction
enzymes and cloned into pACYC184 treated BamHI
and SalI. To generate pJLT24, pJLT25 and pJLT26,
DNA fragments corresponding to the relevant escU
allele were amplified by PCR using primers HAEscU
and EscURevBglII using plasmid DNA as template. The
resulting PCR products were purified and sub-cloned
into pFLAG-CTC vector using XhoI and BglII.
To generate pTir-bla, primers XH1 and XH2 were
used to PCR amplify the tir open reading frame (without
the stop codon) using EPEC genomic DNA as template.
The resulting PCR product was treated with AseIa n d
EcoRI and cloned into NdeI/EcoRI treated pCX341 (gen-
erously provided by I. Rosenshine) [43] to create pTir-
bla. The resulting plasmid construct was electroporated
into EPEC and transformants were selected using tetra-
cycline. Expression of Tir-TEM1 was verified by
immunoblotting using anti-TEM1 antibodies (QED
Biosciences).
Construction of mutants in EPEC E2348/69
A chromosomal deletion of escU was generated using
allelic exchange [39]. Chromosomal DNA regions flank-
ing the escU open reading frame were amplified from
EPEC genomic DNA by PCR using primer pairs JT1/
JT2 and JT3/JT4. The resulting 0.9 kb and 1.2 kb pro-
ducts were treated with NheI and then combined in a
1:1 ratio followed by the addition of T4 DNA ligase.
After an overnight incubation at 16°C, an aliquot of the
ligation reaction was then added to a PCR with primers
JT1 and JT4 which generated a 2.1 kb product. The pro-
duct was digested with SacI and cloned into pRE112
using E. coli DH5alpir as a cloning host. The resulting
plasmid PΔescU was verified using primers JT1 and JT4
by sequencing. PΔescU was then transformed into the
conjugative strain SM10lpir which was then mated with
EPEC E2348/69. EPEC integrants harbouring PΔescU on
the chromosome were selected by plating onto solid
media supplemented with streptomycin and chloram-
phenicol. The resulting colonies were then plated onto
sucrose media (1% [w/v] tryptone, 0.5% [w/v] yeast
extract, 5% [w/v] sucrose and 1.5% [w/v] agar) and incu-
bated overnight at 30°C. The resulting colonies were
screened for sensitivity to chloramphenicol, followed by
a PCR using primers JT1 and JT7 to verify deletion of
the escU from the chromosome. Cis-complementation
mutants were generated using the same allelic exchange
Table 2 Primers used in this study
Primer Sequence (5’-3’)
HAEscU CCGCTCGAGTACCCATACGATGTTCCAGATTACGCTATGAGTGAAAAAACAGAAAAGCCC
EscURevBglII GAAGATCTATAATCAAGGTCTATCGCAATACG
JT1 CCGAGCTCGTTACAGGATCAAACATTGCC
JT2 GCGCTAGCTTCACTCATTAATCATGCTCGG
JT3 CCGCTAGCCTTGATTATTAATCGATAATTTGC
JT4 GCCTCGTGGGCAATATCATTGCG
JT7 CCAAATGCAGTAGAACTCAGAAGGC
JT8 GGGGATCCCTGACATAATTGATAGATCGTTACCG
JT10 ACATGCATGCTCAGTGGTGGTGGTGGTGGT
JT12 /PHOS/GTTATTGTTAAAGCCCCGACTCACATT
JT13 /PHOS/GTTTGATTTTTTGATGTTATTCGC
JT14 /PHOS/GTTAAAAACGCGACTCACATTGCG
JT15 /PHOS/AATAACGGTTGATTTTTTGATGTTATT
NT278
NT279
NT281
NT282
AAGGCGCCTTTTTAACAATAACGGTTGA
AAGGCGCCGACTCACATTGCGATTTGCCTA
GCGACTCACATTGCGATTTGCCTA
GTTTTTAACAATAACGGTTGATT
XH1 CCATTAATATGTCTACAGGAGCATTAGG
XH2 CGGAATTCTCAACGAAACGTACTGGTCC
/PHOS/indicated primers that are 5’ phosphorylated, restriction sites have been underlined.
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(N262A) and primers NT281 and NT282 for escU
(P263A) genetic constructs. To generate the ΔescNΔescU
and ΔsepDΔescU double mutants, SM10lpir/PΔescU
was conjugated with ΔescN [65], ΔsepD [66] as
described above. For genetic trans-complementation stu-
dies, the appropriate plasmids were transformed into
electrocompetent strains followed by antibiotic selection.
In vitro secretion assay
Secretion assays were performed as previously described
[39] with some minor modifications. To aid in the preci-
pitation of proteins from secreted protein fractions,
bovine serum albumin (100 ng) was added as a carrier
protein during the precipitation step.
Isolation of bacterial membrane fractions
Total crude bacterial membrane preparations were gen-
erated from EPEC strains using a previously established
protocol that preserves peripherally associated proteins
and enriches for T3SS needle complexes [39]. Fractiona-
tion of membrane preparations was achieved using
sucrose density gradients as previously described [39].
Immunoprecipitation
Immunoprecipitations with EPEC cell lysates were per-
formed as previously described [39]. Briefly, 500 ng of
affinity purified polyclonal anti-CesT antibody was
added to 50 μl of Protein A conjugated agarose beads
(Invitrogen) followed by washing as directed by the
manufacturer. The antibody-bead mixture was blocked
in phosphate buffered saline (PBS, 137 mM NaCl, 2.7
mM KCl, 4.3 mM Na2HPO4, 1.47 mM KH2PO4) supple-
mented with 1% (w/v) bovine serum albumin and then
added to lysate preparations and incubated overnight at
4°C on a rotator. The samples were gently pelleted and
the agarose beads were washed 3 times with PBS. The
agarose beads were then exposed to 100 mM glycine
(pH 2.2) to elute bound proteins and neutralized with 1
M Tris (pH 8.8) and then prepared for SDS-PAGE.
Infection of HeLa cells
HeLa cells [American Type Culture Collection (ATCC)]
were seeded onto sterile glass coverslips at a density of
1×1 0
5 /ml, grown for 24 hrs and then infected with
various EPEC strains at a multiplicity of infection of 50
for 3 hours. The infected HeLa cells were then prepared
for microscopy as previously described [35]. Images
were detected using a Zeiss Axiovert 200 inverted
microscope and captured using a Hamamatsu ORCA-R2
digital camera. Microscopy based quantification of EPEC
intimate adherence (binding index) was performed as
previously described [67]. Briefly, GFP positive bacteria
(which were identified by GFP fluorescence) that were
associated with actin pedestals were quantified. At least
50 cells were examined per sample.
b-lactamase reporter assays
Type III effector-TEM1 fusion reporter assays for EPEC
strains were performed as previously described [42] with
minor modifications. Briefly, HeLa cells (seeded to con-
fluence in 96 well, black, clear bottom plates [Costar
3603]) were infected with a MOI of approximately 50
for 2 hours using bacteria that had been pre-activated in
DMEM +10% FBS for 2 hours at 37°C, 5% CO2. After 1
hour of infection, IPTG was added to a final concentra-
tion of 0.5 mM. The infected cells were gently washed
twice with DMEM and then loaded with CCF2/AM
using a Toxblazer kit (Invitrogen). The 96 well plate was
i n c u b a t e df o r9 0m i ni nt h ed a r ka n dt h e np l a c e di na
Victor X plate reader (Perkin Elmer) set to read fluores-
cence using an excitation filter for 405 nm and emission
filters for 460 nm (blue signal)/530 nm (green signal).
Blue/green signal ratios and statistical significance (two
sided Student’s t test) were calculated as previously
described [42]. The presented data are mean values of
the results from three experiments.
Protein electrophoresis and Immunoblotting
All protein samples were separated by SDS-PAGE as
described [68]. Separated polypeptides were visualized
by Coomassie G-250 blue staining or Sypro Ruby Red
(Bio-Rad, according to manufacturers directions). Pre-
stained Broad Range Protein Markers (New England
Biolabs, cat. # 7708) were used for standards. For immu-
noblotting, separated polypeptides were transferred to
Immobilon-P membrane (Millipore), blocked with skim
milk (5% [w/v] in Tris buffered saline + Tween20 [TBS-
T]) or BSA, and then incubated with specific antibodies
at working concentrations; anti-EscJ, 1:500 [69]; anti-
EscN, 1/500 [39]; anti-EspB, 1:200 [70]; anti-EspA [71];
anti-intimin 1:1000 (gift from J. Leong); anti-HA, 1:5000
( g i f tf r o mR .D u n c a n ) ;a n t i - F L A G ,1 : 5 0 0 0( S i g m a ) ;a n t i -
DnaK, 1:5000 (Calbiochem), anti-Tir, 1:1000 [35]; anti-
TEM1, 1:2000 (QED Biosciences); goat anti-mouse con-
jugated to horse radish peroxidise (HRP), 1:5000 (Rock-
land immunochemicals); goat anti-rabbit conjugated to
HRP, 1:5000 (Rockland immunochemicals); goat anti-rat
conjugated to HRP, 1:5000. Anti-CesT polyclonal anti-
bodies were raised in New Zealand white rabbits against
a synthetic peptide (LENEHMKIEEISSSDNK) corre-
sponding to the C-terminal region of CesT (Pacific
Immunology, CA, USA, [NIH Animal Welfare Assur-
ance Number: A4182-01]). Final bleeds were affinity
purified against the peptide by the supplier and used in
immunoblots at a 1:10000 dilution. Immunoblots were
developed using an enhanced chemiluminescence
reagent (ECL, GE Healthcare) and data captured on a
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Page 14 of 17VersaDoc 5000 MP (Bio-Rad). Densitometry measure-
ments to evaluate band intensity from chemiluminescent
signals in immunoblotting experiments were performed
using Quantity One software (Bio-Rad). Immunoblots
were imaged simultaneously and within exposure times
that were within an empirically determined linear range
of signal detection.
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